Taketomi T., Nishimura K.Physiological activity of psychosine. Jpn J Exp Med . 1964;34:255-265.
4.
Given CA II, Santos CC, Durden DDIntracranial and spinal MR imaging findings associated with Krabbe’s disease: case report. AJNR Am J Neuroradiol. 2001;22:1782-1785.
5.
Matsuda J., Vanier MT, Saito Y., et al. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene causes a late-onset, slowly progressive form of globoid cell leukodystrophy in the mouse. Hum Mol Genet. 2001;10:1191-1199.
6.
Spiegel R., Bach G., Sury V., et al. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Mol Genet Metab. 2005 ;84:160-166.
Duffner PK, Caviness VS Jr, Erbe RW, et al. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York. Genet Med. 2009;11: 450-454.
Brockmann K. , Dechent P., Wilken B., Rusch O., Frahm J., Hanefeld F.Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology. 2003;60: 819-825.
11.
Blüml S., Moreno A., Hwang JH, Ross BD1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed. 2001;14:19-32.
